SLRX Salarius Pharmaceuticals
- 2.3000
- +0.2400+11.65%
- 2.2100
- -0.0900-3.91%
Salarius Pharmaceuticals News
Salarius Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
(SLRX) - Analyzing Salarius Pharmaceuticals's Short Interest
Express News | Salarius Pharmaceuticals Shares Resume Trade
Express News | Salarius Pharmaceuticals Shares Halted On Circuit Breaker To The Downside, Stock Now Up 19.1%
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Trending Stocks Today | Psyence Biomedical Surges 50.16%
Dow Jumps 200 Points; Honeywell Trims Profit Outlook
Trending Stocks Today | Azitra Surges 286.15%
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Why Tellurian Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
Express News | Salarius Pharmaceuticals: To Continue Support for Mdacc's Sponsored Clinical Trial Evaluating Seclidemstat (SP-2577) in Combination With Azacitidine
Express News | Salarius Pharmaceuticals Inc: Continues Its Exploration of Potential Strategic Alternatives
Express News | Salarius Pharmaceuticals Inc - Terminating the Ongoing Clinical Trial in an Effort to Conserve Cash
Express News | Salarius Pharmaceuticals Inc: Now Determined to Close Ongoing Phase 1/2 Clinical Trial Evaluating Seclidemstat for Ewing Sarcoma
Why Selective Insurance Group Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Why Intuitive Surgical Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Sector Update: Health Care Stocks Advance in Afternoon Trading
Top Midday Decliners
Sector Update: Health Care
Express News | Salarius Pharmaceuticals Shares Down 21.6% Premarket as FDA Puts Cancer Drug Trial on Partial Clinical Hold
Analysis
Price Target
No Data
